デフォルト表紙
市場調査レポート
商品コード
1766583

局所鎮痛剤市場:製品タイプ別、有効成分別、タイプ別、用途別、患者層別、流通チャネル別、地域別

Topical Pain Relief Market, By Product Type, By Active Ingredient, By Type, By Application, By Patient Demographics, By Distribution Channel, By Geography


出版日
ページ情報
英文 135 Pages
納期
2~3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=150.05円
局所鎮痛剤市場:製品タイプ別、有効成分別、タイプ別、用途別、患者層別、流通チャネル別、地域別
出版日: 2025年06月06日
発行: Coherent Market Insights
ページ情報: 英文 135 Pages
納期: 2~3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

局所鎮痛剤市場は、2025年には111億米ドルと推定され、2032年には159億3,000万米ドルに達すると予測され、2025年から2032年までの年間平均成長率(CAGR)は5.3%で成長する見込みです。

レポート範囲 レポート詳細
基準年 2024 2025年の市場規模 111億米ドル
実績データ 2020年から2024年まで 予測期間 2025年から2032年
予測期間:2025年~2032年CAGR: 5.30% 2032年の価値予測 159億3,000万米ドル

世界の局所疼痛緩和市場は、慢性疼痛疾患の有病率の増加、高齢者人口の増加、局所疼痛管理ソリューションの利点に対する意識の高まりなどを背景に、近年大きな成長を遂げています。局所疼痛緩和製品は、有効成分を患部に直接投与することで局所的な疼痛緩和を提供し、全身への曝露を最小限に抑え、経口鎮痛剤に伴う副作用のリスクを低減します。この市場には、非ステロイド性抗炎症薬(NSAIDs)、メントール、カプサイシン、リドカインなど、さまざまな有効成分を配合したクリーム、ジェル、スプレー、パッチ、軟膏など、幅広い製品があります。急性および慢性の疼痛管理に安全で効果的な選択肢を求める消費者が増えていることから、局所鎮痛剤の需要は今後も伸び続けると予想されます。

市場力学

世界の局所鎮痛剤市場は、長期的な疼痛管理ソリューションを必要とする関節炎、腰痛、スポーツ傷害などの慢性疼痛症状の有病率の上昇など、いくつかの要因によって牽引されています。また、高齢者は慢性疼痛状態に陥りやすいため、世界の高齢者人口の増加も市場の成長に寄与しています。さらに、経口鎮痛剤に伴う副作用に対する意識の高まりから、全身への影響を最小限に抑えながら局所的な痛みを緩和する局所鎮痛剤へと消費者の嗜好がシフトしています。しかし、経口薬や理学療法などの代替疼痛管理オプションが利用可能であることや、重度の疼痛状態に対する一部の局所用製品の有効性が限定的であることが、市場の成長を抑制する可能性があります。さらに、新しい疼痛緩和外用剤の承認に関する規制ガイドラインが厳しいことも、市場参入者にとって課題となる可能性があります。このような市場抑制要因はあるもの、天然素材やオーガニックの疼痛緩和製品に対する需要の高まり、新規ドラッグデリバリーシステムの市場開拓、eコマースプラットフォームを含む流通チャネルの拡大が、市場に大きな成長機会をもたらしています。

本調査の主な特徴

  • 本レポートでは、世界の局所鎮痛剤市場を詳細に分析し、2024年を基準年とした予測期間(2025-2032年)の市場規模(10億米ドル)と年間平均成長率(CAGR%)を掲載しています。
  • また、さまざまなセグメントにわたる潜在的な収益機会を明らかにし、この市場の魅力的な投資提案マトリクスについて説明しています。
  • また、市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域別の展望、主要企業が採用する競争戦略などに関する重要な考察も提供しています。
  • 企業ハイライト、製品ポートフォリオ、主要なハイライト、業績、戦略などのパラメータに基づいて、世界の局所鎮痛剤市場における主要企業プロファイルを掲載しています。
  • 本レポートからの洞察により、マーケティング担当者や企業の経営陣は、将来の製品発売、タイプアップ、市場拡大、マーケティング戦術に関する情報に基づいた意思決定を行うことができます。
  • この調査レポートは、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この業界の様々な利害関係者を対象としています。
  • 利害関係者は、世界の局所鎮痛剤市場の分析に使用される様々な戦略マトリックスを通じて、意思決定が容易になります。

目次

第1章 調査の目的と前提条件

  • 調査目的
  • 前提条件
  • 略語

第2章 市場の展望

  • レポートの説明
    • 市場の定義と範囲
  • エグゼクティブサマリー

第3章 市場力学、規制、動向分析

  • 市場力学
  • 促進要因
  • 抑制要因
  • 機会
  • 影響分析
  • 主な発展
  • 規制シナリオ
  • 製品の発売/承認
  • PEST分析
  • PORTERの分析
  • 合併と買収のシナリオ
  • 業界動向

第4章 世界の局所鎮痛剤市場、製品タイプ別、2020年~2032年

  • ゲル
  • クリーム
  • 軟膏
  • パッチ
  • スプレー
  • ロールオン

第5章 世界の局所鎮痛剤市場、有効成分別、2020年~2032年

  • 非ステロイド性抗炎症薬(NSAID)
  • 抗刺激剤
  • 麻酔薬
  • サリチル酸塩
  • カプサイシン
  • メントール

第6章 世界の局所鎮痛剤市場、タイプ別、2020年~2032年

  • 処方鎮痛剤
  • 市販の鎮痛剤

第7章 世界の局所鎮痛剤市場、用途別、2020年~2032年

  • 関節炎の痛み
  • 筋肉と関節の痛み
  • 腰痛
  • スポーツ傷害
  • 神経障害性疼痛
  • 術後の痛み

第8章 世界の局所鎮痛剤市場、患者層別、2020年~2032年

  • 大人
  • 高齢者
  • 小児

第9章 世界の局所鎮痛剤市場、流通チャネル別、2020年~2032年

  • オンライン薬局
  • 小売薬局
  • 病院薬局
  • スーパーマーケット/ハイパーマーケット
  • 健康とウェルネスストア

第10章 世界の局所鎮痛剤市場、地域別、2020年~2032年

  • 北米
      • 米国
      • カナダ
  • ラテンアメリカ
      • ブラジル
      • アルゼンチン
      • メキシコ
      • その他ラテンアメリカ
  • 欧州
      • ドイツ
      • 英国
      • スペイン
      • フランス
      • イタリア
      • ロシア
      • その他欧州
  • アジア太平洋
      • 中国
      • インド
      • 日本
      • オーストラリア
      • 韓国
      • ASEAN
      • その他アジア太平洋地域
  • 中東
      • GCC諸国
      • イスラエル
      • その他中東
  • アフリカ
      • 南アフリカ
      • 北アフリカ
      • 中央アフリカ

第11章 競合情勢

  • Johnson & Johnson
  • Pfizer Inc.
  • GlaxoSmithKline
  • Bayer AG
  • Novartis AG
  • Sanofi S.A.
  • Merck & Co., Inc.
  • Abbott Laboratories
  • Amgen Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Astellas Pharma Inc.
  • Mylan N.V.
  • Reckitt Benckiser Group plc
  • Hisamitsu Pharmaceutical Co., Inc.
  • Mentholatum Company, Inc.

第12章 アナリストの推奨事項

  • 機会
  • アナリストの見解
  • Coherent Opportunity Map

第13章 参考文献と調査手法

  • 参考文献
  • 調査手法
  • 出版社について
目次
Product Code: CMI8051

Topical Pain Relief Market is estimated to be valued at USD 11.10 Bn in 2025 and is expected to reach USD 15.93 Bn by 2032, growing at a compound annual growth rate (CAGR) of 5.3% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 11.10 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 5.30% 2032 Value Projection: USD 15.93 Bn

The global topical pain relief market has witnessed significant growth in recent years, driven by the increasing prevalence of chronic pain conditions, rising geriatric population, and growing awareness about the benefits of topical pain management solutions. Topical pain relief products offer localized pain relief by delivering active ingredients directly to the affected area, minimizing systemic exposure and reducing the risk of adverse effects associated with oral pain medications. The market encompasses a wide range of products, including creams, gels, sprays, patches, and ointments, formulated with various active ingredients such as non-steroidal anti-inflammatory drugs (NSAIDs), menthol, capsaicin, and lidocaine. The demand for topical pain relief products is expected to continue growing as more consumers seek safe and effective options for managing acute and chronic pain conditions.

Market Dynamics

The global topical pain relief market is driven by several factors, including the rising prevalence of chronic pain conditions, such as arthritis, back pain, and sports injuries, which require long-term pain management solutions. The growing geriatric population worldwide is also contributing to the market growth, as older adults are more susceptible to chronic pain conditions. Moreover, the increasing awareness about the side effects associated with oral pain medications has led to a shift in consumer preference towards topical pain relief products, which offer localized pain relief with minimal systemic exposure. However, the market growth may be restrained by the availability of alternative pain management options, such as oral medications and physical therapy, as well as the limited efficacy of some topical products for severe pain conditions. Additionally, stringent regulatory guidelines for the approval of new topical pain relief products may pose challenges for market players. Despite these restraints, the market presents significant opportunities for growth, driven by the increasing demand for natural and organic pain relief products, the development of novel drug delivery systems, and the expansion of distribution channels, including e-commerce platforms.

Key Features of the Study

  • This report provides in-depth analysis of the global topical pain relief market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global topical pain relief market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Johnson & Johnson, Pfizer Inc., GlaxoSmithKline, Bayer AG, Novartis AG, Sanofi S.A., Merck & Co., Inc., Abbott Laboratories, Amgen Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Mylan N.V., Reckitt Benckiser Group plc, Hisamitsu Pharmaceutical Co., Inc., and Mentholatum Company, Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global topical pain relief market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global topical pain relief market.

Market Segmentation

  • Product Type Insights (Revenue, USD Bn, 2020 - 2032)
    • Gels
    • Creams
    • Ointments
    • Patches
    • Sprays
    • Roll-ons
  • Active Ingredient Insights (Revenue, USD Bn, 2020 - 2032)
    • Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
    • Counterirritants
    • Anesthetics
    • Salicylates
    • Capsaicin
    • Menthol
  • Type Insights (Revenue, USD Bn, 2020 - 2032)
    • Prescription Pain Relief
    • Over-the-Counter (OTC) Pain Relief
  • Application Insights (Revenue, USD Bn, 2020 - 2032)
    • Arthritis Pain
    • Muscle and Joint Pain
    • Back Pain
    • Sports Injuries
    • Neuropathic Pain
    • Post-Surgical Pain
  • Patient Demographics Insights (Revenue, USD Bn, 2020 - 2032)
    • Adults
    • Geriatrics
    • Pediatrics
  • Distribution Channel Insights (Revenue, USD Bn, 2020 - 2032)
    • Online Pharmacies
    • Retail Pharmacies
    • Hospitals Pharmacy
    • Supermarkets/Hypermarkets
    • Health and Wellness Stores
  • Regional Insights (Revenue, USD Bn, 2020 - 2032)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • Johnson & Johnson
    • Pfizer Inc.
    • GlaxoSmithKline
    • Bayer AG
    • Novartis AG
    • Sanofi S.A.
    • Merck & Co., Inc.
    • Abbott Laboratories
    • Amgen Inc.
    • Teva Pharmaceutical Industries Ltd.
    • Astellas Pharma Inc.
    • Mylan N.V.
    • Reckitt Benckiser Group plc
    • Hisamitsu Pharmaceutical Co., Inc.
    • Mentholatum Company, Inc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Topical Pain Relief Market, By Product Type
    • Global Topical Pain Relief Market, By Active Ingredient
    • Global Topical Pain Relief Market, By Type
    • Global Topical Pain Relief Market, By Application
    • Global Topical Pain Relief Market, By Patient Demographics
    • Global Topical Pain Relief Market, By Distribution Channel
    • Global Topical Pain Relief Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Driver
  • Restraint
  • Opportunity
  • Impact Analysis
  • Key Developments
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario
  • Industry Trends

4. Global Topical Pain Relief Market, By Product Type, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Gels
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Creams
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Ointments
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Patches
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Sprays
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Roll-ons
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Topical Pain Relief Market, By Active Ingredient, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Counterirritants
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Anesthetics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Salicylates
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Capsaicin
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Menthol
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Topical Pain Relief Market, By Type, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Prescription Pain Relief
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Over-the-Counter (OTC) Pain Relief
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Topical Pain Relief Market, By Application, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Arthritis Pain
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Muscle and Joint Pain
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Back Pain
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Sports Injuries
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Neuropathic Pain
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Post-Surgical Pain
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Topical Pain Relief Market, By Patient Demographics, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Adults
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Geriatrics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Pediatrics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Topical Pain Relief Market, By Distribution Channel, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Hospitals Pharmacy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Supermarkets/Hypermarkets
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Health and Wellness Stores
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

10. Global Topical Pain Relief Market, By Region, 2020 - 2032, Value (USD Bn)

  • Introduction
    • Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
    • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Active Ingredient, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Patient Demographics, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Active Ingredient, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Patient Demographics, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Active Ingredient, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Patient Demographics, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Active Ingredient, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Patient Demographics, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Active Ingredient, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Patient Demographics, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Active Ingredient, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Patient Demographics, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
      • South Africa
      • North Africa
      • Central Africa

11. Competitive Landscape

  • Johnson & Johnson
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Pfizer Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • GlaxoSmithKline
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Bayer AG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Novartis AG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Sanofi S.A.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Merck & Co., Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Abbott Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Amgen Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Teva Pharmaceutical Industries Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Astellas Pharma Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Mylan N.V.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Reckitt Benckiser Group plc
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Hisamitsu Pharmaceutical Co., Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Mentholatum Company, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

12. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

13. References and Research Methodology

  • References
  • Research Methodology
  • About us